NAA20
N-alpha-acetyltransferase 20
Also known as: dJ1002M8.1, NAA20_HUMAN, NAT3, NAT5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P61599
- Gene
- NAA20
- Ensembl
- ENSG00000173418
- Chromosome
- 20
- Canonical length
- 178 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
NAT5 is a component of N-acetyltransferase complex B (NatB). Human NatB performs cotranslational N(alpha)-terminal acetylation of methionine residues when they are followed by asparagine (Starheim et al., 2008 [PubMed 18570629]).[supplied by OMIM, Apr 2009]
Canonical amino-acid sequenceUniProt
178 residues, UniProt reviewed canonical sequence.
>P61599|NAA20
1 MTTLRAFTCD DLFRFNNINL DPLTETYGIP FYLQYLAHWP EYFIVAEAPG GELMGYIMGK
61 AEGSVAREEW HGHVTALSVA PEFRRLGLAA KLMELLEEIS ERKGGFFVDL FVRVSNQVAV
121 NMYKQLGYSV YRTVIEYYSA SNGEPDEDAY DMRKALSRDT EKKSIIPLPH PVRPEDIELocalizationUniProt · AlphaFold · HPA
Whether an antibody against NAA20 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 173 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 173 nTPM
- choroid plexus: 122 nTPM
- skeletal muscle: 113 nTPM
- parathyroid gland: 98 nTPM
- kidney: 79 nTPM
- liver: 77 nTPM
Single-cell type
- esophageal apical cells: 1,709 nCPM
- late primary spermatocytes: 858 nCPM
- esophageal suprabasal cells: 781 nCPM
- hofbauer cells: 431 nCPM
- esophageal basal cells: 394 nCPM
- early spermatids: 309 nCPM
Immune cell
- total PBMC: 101 nTPM
- intermediate monocyte: 98 nTPM
- myeloid DC: 93 nTPM
- classical monocyte: 86 nTPM
- MAIT T-cell: 84 nTPM
- non-classical monocyte: 82 nTPM
Brain region
- choroid plexus: 63 nTPM
- white matter: 42 nTPM
- hypothalamus: 39 nTPM
- spinal cord: 38 nTPM
- cerebral cortex: 37 nTPM
- thalamus: 37 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NAA20.
Disease | AllUniProt
Conditions NAA20 is implicated in, by any mechanism.
- Intellectual developmental disorder, autosomal recessive 73 (MRT73) MIM:619717
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 28 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual developmental disorder, autosomal recessive 73
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.31
- DepMap mean gene effect
- -0.84
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- N-terminal peptidyl-aspartic acid acetylation
- N-terminal peptidyl-glutamic acid acetylation
- N-terminal protein amino acid acetylation
- regulation of actin cytoskeleton organization
- N-terminal peptidyl-glutamine acetylation
Molecular functions
- protein N-terminal-methionine acetyltransferase activity
- protein-N-terminal amino-acid acetyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GNAT domain
- Acyl-CoA N-acyltransferase
- Acetyltransferase (GNAT) family
- N-terminal NatB acetyltransferase catalytic subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NAA20 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NAA20 as an antibody target. Whether an autoantibody or antibody against NAA20 could matter depends on whether native NAA20 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NAA20 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NAA20 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...